Prevalence of the FMR1 mutation in Taiwan assessed by large-scale screening of newborn boys and analysis of DXS548-FRAXAC1 haplotype

American Journal of Medical Genetics

Volumn 133 A, Issue 1, 2005, Pages 37-43

  Tzeng, Ching Cherng ^a   Tsai, Li Ping ^b   Hwu, Wuh Liang ^c   Lin, Shio Jean ^d   Chao, Mei Chyn ^e   Jong, Yuh Jyh ^e   Chu, Shao Yin ^f   Chao, Wei Chen ^a   Lu, Chin Li ^a  

^a CHI MEI MEDICAL CENTER   (Taiwan)

^b Taipei Munic Women's Children's H ^*  (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^d DEPARTMENT OF HEALTH   (Taiwan)

^e KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^f BUDDHIST TZU CHI GENERAL HOSPITAL   (Taiwan)

Author keywords

Bloodspot; DXS548 FRAXAC1 haplotype; FMR1 gene; Fragile X syndrome; Prevalence

Indexed keywords

FRAGILE X MENTAL RETARDATION PROTEIN; MICROSATELLITE DNA;

ARTICLE; CONTROLLED STUDY; FRAGILE X SYNDROME; GENE FREQUENCY; GENE MUTATION; HAPLOTYPE; HUMAN; MALE; NEWBORN; NEWBORN SCREENING; POLYMERASE CHAIN REACTION; PREVALENCE; PRIORITY JOURNAL; TAIWAN;

ALLELES; CHROMOSOMES, HUMAN, X; DNA; FRAGILE X MENTAL RETARDATION PROTEIN; FRAGILE X SYNDROME; GENE FREQUENCY; GENETIC SCREENING; HAPLOTYPES; HUMANS; INFANT, NEWBORN; MALE; MICROSATELLITE REPEATS; MUTATION; NERVE TISSUE PROTEINS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PREVALENCE; RNA-BINDING PROTEINS; TAIWAN; TRINUCLEOTIDE REPEATS;

EID: 12944300322     PISSN: 15524825     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.a.30528     Document Type: Article

References (44)

1. Artigas Pallares J, Brun Gasca C. 2001. Medical treatment of fragile X syndrome. Rev Neurol 33:S41-S50.
2. Arvio M, Peippo M, Simola KO. 1997. Applicability of a checklist for clinical screening of the fragile X syndrome. Clin Genet 52:211-215.
3. Bonaventure G, Torrado M, Barreiro C, Chertkoff L. 1998. Fragile X founder effects in Argentina. Am J Med Genet 79:200-204.
4. Brown WT, Houck GE Jr, Jeziorowska A, Levinson FN, Ding X, Dobkin C, Zhong N, Henderson J, Brooks SS, Jenkins EC. 1993. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA 270:1569-1575.
5. Buyle S, Reyniers E, Vits L, De Boulle K, Handig I, Wuyts FL, Deelen W, Halley DJ, Oostra BA, Willems PJ. 1993. Founder effect in a Belgian-Dutch fragile X population. Hum Genet 92:269-272.
6. Chiang SC, Lee YM, Wang TR, Hwu WL. 1999. Allele distribution at the FMR1 locus in the general Chinese population. Clin Genet 55:352-355.
7. Chiurazzi P, Macpherson J, Sherman S, Neri G. 1996a. Significance of linkage disequilibrium between the fragile X locus and its flanking markers. Am J Med Genet 64:203-208.
8. Chiurazzi P, Genuardi M, Kozak L, Giovannucci-Uzielli ML, Bussani C, Dagna-Bricarelli F, Grasso M, Perroni L, Sebastio G, Sperandeo MP, Oostra BA, Neri G. 1996b. Fragile X founder chromosomes in Italy: A few initial events and possible explanation for their heterogeneity. Am J Med Genet 64:209-215.
9. Dombrowski C, Lévesque S, Morel ML, Rouillard P, Morgan K, Rousseau F. 2002. Premutation and intermediate-size FMR1 alleles in 10572 males from the general population: Loss of an AGG interruption is a late event in the generation of fragile X syndrome alleles. Hum Mol Genet 11:371-378.
10. Eichler EE, Macpherson JN, Murray A, Jacobs PA, Chakravarti A, Nelson DL. 1996. Haplotype and interspersion analysis of the FMR1 CGG repeat identifies two different mutational pathways for the origin of the fragile X syndrome. Hum Mol Genet 5:319-330.
11. Falik-Zaccai TC, Shachak E, Yalon M, Lis Z, Borochowitz Z, Macpherson JN, Nelson DL, Eichler EE. 1997. Predisposition to the fragile X syndrome in Jews of Tunisian descent is due to the absence of AGG interruptions on a rare Mediterranean haplotype. Am J Hum Genet 60:103-112.
12. Hagerman RJ, Amiri K, Cronister A. 1991. Fragile X checklist. Am J Med Genet 38:283-287.
13. Huang KF, Chen WY, Tsai YC, Lin CC, Chen SH, Tseng CY, Tzeng CC. 2003. Pilot screening of fragile X carrier in pregnant women of Southern Taiwan. J Chin Med Assoc 66:204-209.
14. Kolehmainen K. 1994. Population genetics of fragile X: A multiple allele model with variable risk of CGG repeat expansion. Am J Med Genet 51:428-435.
15. Kremer EJ, Pritchard M, Lynch M, Yu S, Holman K, Baker E, Warren ST, Schlessinger D, Sutherland GR, Richards RI. 1991. Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CGG)n. Science 252:1711-1714.
16. Macpherson JN, Bullman H, Youings SA, Jacobs PA. 1994. Insert size and flanking haplotype in fragile X and normal populations: Possible multiple origins for the fragile X mutation. Hum Mol Genet 3:399-405.
17. Maddalena A, Richards CS, McGinniss MJ, Brothman A, Desnick RJ, Grier RE, Hirsch B, Jacky P, McDowell GA, Popovich B, Watson M, Wolff DJ. 2001. Technical standards and guidelines for fragile X: The first of a series of disease-specific supplements to the Standards and Guidelines for Clinical Genetics Laboratories of the American College of Medical Genetics. Quality Assurance Subcommittee of the Laboratory Practice Committee. Genet Med 3:200-205.
18. Mingroni-Netto RC, Costa SS, Angeli CB, Vianna-Morgante AM. 1999. DXS548/FRAXAC1 haplotypes in fragile X chromosomes in the Brazilian population. Am J Med Genet 84:204-207.
19. Morris A, Morton NE, Collins A, Macpherson J, Nelson D, Sherman S. 1995. An n-allele model for progressive amplification in the FMR1 locus. Proc Natl Acad Sci USA 92:4833-4837.
20. Morton NE, MacPherson JN. 1992. Population genetics of the fragile-X syndrome: Multiallelic model for the FMR1 locus. Proc Natl Acad Sci USA 89:4215-4217.
21. Nolin SL, Brown WT, Glicksman A, Houck GE Jr, Gargano AD, Sullivan A, Biancalana V, Brondum-Nielsen K, Hjalgrim H, Holinski-Feder E, Kooy F, Longshore J, Macpherson J, Mandel JL, Matthijs G, Rousseau F, Steinbach P, Vaisanen ML, von Koskull H, Sherman SL. 2003. Expansion of the fragile X CGG repeat in females with premutation or intermediate alleles. Am J Hum Genet 72:454-464.
22. Oudet C, von Koskull H, Nordstrom AM, Peippo M, Mandel JL. 1993. Striking founder effect for the fragile X syndrome in Finland. Eur J Hum Genet 1:181-189.
23. Pang CP, Poon PM, Chen QL, Lai KY, Yin CH, Zhao Z, Zhong N, Lau CH, Lam ST, Wong CK, Brown WT. 1999. Trinucleotide CGG repeat in the FMR1 gene in Chinese mentally retarded patients. Am J Med Genet 84:179-183.
24. Patsalis PC, Sismani C, Hettinger JA, Holden JJ, Lawson JS, Chalifoux M, Wing M, Walker M, Leggo J. 1999. Frequencies of "grey-zone" and premutation-size FMR1 CGG-repeat alleles in patients with developmental disability in Cyprus and Canada. Am J Med Genet 84:195-197.
25. Pekarìk V, Blazkova M, Kozak L. 1999. Haplotype analysis of the fragile X syndrome gene FMR1 in the Czech Republic. Am J Med Genet 84:214-216.
26. Pesso R, Barkai G, Ravia Y, Gak E, Frydman M, Goldman B, Friedman E. 1997. No founder effect detected in Jewish Ashkenazi patients with fragile-X syndrome. Hum Genet 101:186-189.
27. Poon PM, Pang CP, Chen QL, Zhong N, Lai KY, Lau CH, Wong CK, Brown WT. 1999. FRAXAC1 and DXS548 polymorphisms in the Chinese population. Am J Med Genet 84:208-213.
28. Richards RI, Holman K, Kozman H, Kremer E, Lynch M, Pritchard M, Yu S, Mulley J, Sutherland GR. 1991. Fragile X syndrome: genetic localisation by linkage mapping of two microsatellite repeats FRAXAC1 and FRAXAC2 which immediately flank the fragile site. J Med Genet 28:818-823.
29. Rifé M, Badenas C, Mallolas J, Jiménez L, Cervera R, Maya A, Glover G, Rivera F, Milà M. 2003. Incidence of fragile X in 5,000 consecutive newborn males. Genet Test 7:339-343.
30. Riggins GJ, Sherman SL, Oostra BA, Sutcliffe JS, Feitell D, Nelson DL, van Oost BA, Smits AP, Ramos FJ, Pfendner E, Kuhl DPK, Caskey T, Warren ST. 1992. Characterization of a highly polymorphic dinucleotide repeat 150 KB proximal to the fragile X site. Am J Med Genet 43:237-243.
31. Rousseau F, Rouillard P, Morel M, Khandjian EW, Morgan K. 1995. Prevalence of carriers of premutation-size alleles of the FMR-1 gene and implication for the population genetics of the fragile X syndrome. Am J Hum Genet 57:1006-1028.
32. Ryynänen M, Heinonen S, Makkonen M, Kajanoja E, Mannermaa A, Pertti K. 1999. Feasibility and acceptance of screening for fragile X mutations in low-risk pregnancies. Eur J Hum Genet 7:212-216.
33. Sherman SL. 1996. Epidemiology. In: Hagerman RJ, Cronister A, editors. Fragile X syndrome: Diagnosis, treatment, and research. Baltimore: Johns Hopkins University Press. pp 165-192.
34. Snow K, Doud LK, Hagerman R, Pergolizzi RG, Erster SH, Thibodeau SN. 1993. Analysis of a CGG sequence at the FMR-1 locus in fragile X families and in the general population. Am J Hum Genet 53:1217-1228.
35. Spence WC, Black SH, Fallon L, Maddalena A, Cummings E, Menapace-Drew G, Bick DP, Levinson G, Schulman JD, Howard-Peebles PN. 1996. Molecular fragile X screening in normal populations. Am J Med Genet 64:181-183.
36. Stoll C. 2001. Problems in the diagnosis of fragile X syndrome in young children are still present. Am J Med Genet 100:110-115.
37. Toledano-Alhadef H, Basel-Vanagaite L, Magal N, Davidov B, Ehrlich S, Drasinover V, Taub E, Halpern GJ, Ginott N, Shohat M. 2001. Fragile-X carrier screening and the prevalence of premutation and full-mutation carriers in Israel. Am J Hum Genet 69:351-360.
38. Tzeng CC, Cho WC, Kuo PL, Chen RM. 1999. A pilot fragile X screening in normal population of Taiwan. Diagn Mol Pathol 8:152-156.
39. Tzeng CC, Tzeng PY, Sun HS, Chen RM, Lin SJ. 2000. Implication of screening for FMR1 and FMR2 gene mutation in individuals with nonspecific mental retardation in Taiwan. Diagn Mol Pathol 9:75-80.
40. Tzeng CC, Lin SJ, Chen YJ, Kuo PL, Jong YJ, Tsai LP, Chen RM. 2001. An effective strategy of using molecular test to screen mentally retarded individuals for fragile X syndrome. Diagn Mol Pathol 10:34-40.
41. Verkerk AJMH, Pieretti M, Sutcliffe JS, Fu YH, Kuhl DP, Pizzuti A, Reiner O, Richards S, Victoria MF, Zhang FP, Eussen BE, van Ommen GJB, Blonden LAJ, Riggings GJ, Chastain JL, Kunst CB, Galjarrd H, Caskey CT, Nelson DL, Oostra BA, Warren ST. 1991. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914.
42. Zhong N, Liu X, Gou S, Houck GE Jr, Li S, Dobkin C, Brown WT. 1994. Distribution of FMR-1 and associated microsatellite alleles in a normal Chinese population. Am J Med Genet 51:417-422.
43. Zhong N, Kajanoja E, Smits B, Pietrofesa J, Curley D, Wang D, Ju W, Nolin S, Dobkin C, Ryynanen M, Brown WT. 1996. Fragile X founder effects and new mutations in Finland. Am J Med Genet 64:226-233.
44. Zhong N, Ju W, Xu W, Ye L, Shen Y, Wu G, Chen SH, Jin R, Hu XF, Yang A, Liu X, Poon P, Pang C, Zheng Y, Song L, Zhao P, Fu B, Gu H, Brown WT. 1999. Frequency of the fragile X syndrome in Chinese mentally retarded populations is similar to that in Caucasians. Am J Med Genet 84:191-194.